Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MASTER: Atorvastatin in early breast cancer
NCT04601116Phase 3Recruiting
- Sponsor
- Aarhus University Hospital
- Start
- Jan 2021
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in estrogen receptor-positive breast cancer (ER+), sponsored by Aarhus University Hospital. Started Jan 2021; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
estrogen receptor-positive breast cancer (ER+)
Beyond the preview
Go deeper on NCT04601116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04601116.